I Quit Ordinary Smoking (IQOS)

Venture kept at 'sell' by UOB on grimmer production outlook
SINGAPORE (Dec 6): UOB KayHian is maintaining Venture Corp at “sell” given increasing risk production share of IQOS (I quit ordinary smoking) devices could be shifted away to another contract manufacturer by Philip Morris which is seeking to improve economics. In a Thursday report, analyst Foo Zhi Wei says UOB channel checks into the IQOS supply chain indicate that the second manufacturer, ...
Venture faces 2019 earnings risk due to competition, says UOB Kay Hian
SINGAPORE (Oct 19): UOB Kay Hian is maintaining its “hold” call on Venture Corporation with a target price of $18.20. This comes post the release of Philip Morris International’s (PMI) 3Q earnings statement last night, which reflected strong operating metrics but a more mixed outlook on device production split, in UOB’s view. In a Friday report, analyst Foo Zhiwei says current ...
Positive IQOS sales momentum signals promising 2019 for Venture: UOB
SINGAPORE (Oct 2): UOB Kay Hian is maintaining its “hold” call on Venture Corporation with a recommended entry price of $16 and target price of $18.20, which is pegged to 14 times 2018F P/E. The research house’s rating reiteration follows Philip Morris International’s (PMI) Investor Day 2018 last week, which revealed a pickup in sales of IQOS (I quit ordinary smoking) smoke-free ...
Venture Corp's earnings success to carry on so long as trade war does not escalate: RHB
SINGAPORE (Aug 6): RHB Research is maintaining “buy” on Venture Corp while lowering its target price from $26 to $22.20, which is now pegged to 15.5 times FY18F P/E compared to 17.2 times previously due to the weaker industry outlook. The research house nonetheless remains bullish on the stock after attending the group’s analyst briefing post the release of its 2Q18 financial results ...
Philip Morris' full-year guidance looks negative for Venture Corp
SINGAPORE (July 23): Philip Morris International has significantly cut its full-year guidance as it prepares for the next generation of IQOS (I quit original smoking) devices. The worldwide introduction of the next generation of IQOS devices towards the end of 2018 will require the reduction of current generation device inventories while the ramp-up of new devices is expected to occur in 2019, ...
Venture's stellar performance could go up in smoke soon
SINGAPORE (July 5): Venture Corp’s stellar 2017 was driven by I Quit Ordinary Smoking (IQOS) smokeless cigarette devices. But with IQOS production slowing down and shifting away to its competitor, Venture’s earnings are at risk of declining in 2018 and beyond, say analysts. In a Thursday report, UOB KayHian analysis affirms its initial belief that the IQOS device that Venture ...
Citi keeps Venture at 'buy' saying fears of customer risks unfounded
SINGAPORE (May 8): Citigroup is keeping Venture Corp at “buy” with unchanged $31.74 target, saying sales contribution by Philip Morris International’s looks closer to 12% than the 30% feared by investors. In addition, Venture’s PE valuations are now at 9% discount to Singapore’s market average but with earnings growth at least twice better, says Citi. Indeed, Venture’s stock ...
Slower demand in Japan but Venture expects Europe, South Korea to pick up the slack
SINGAPORE (Apr 24): UOB Kay Hian is maintaining its “buy” call on Venture Corporation with a lower target price of $30.60. In a Monday report, analyst Foo Zhi Wei says Venture's share price has largely overreacted to Phillip Morris International’s (PMI) slower 1Q18 growth of I Quit Ordinary Smoking (IQOS) e-cigarette products in its key market of Japan. This was attributed to sales ...